Dana Crawford

Dr. Dana Crawford


Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 August 2000 in BioTechniques
Verified
Journal Article
Open access
TSToshihide Suzuki
Toshihide Suzuki
PHPaul J. Higgins
Paul J. Higgins
DCDana Crawford
Dana Crawford
The study of mammalian gene expression is often carried out at the level of mRNA. In such analyses, one usually measures the amount of an mRNA of interest under different conditions such as stress,...

4 June 2012 in Journal of Alzheimer’s Disease
Verified
Journal Article
Closed access
PDF file
AMAlex Mathew
Alex Mathew
TLTara A. Lindsley
Tara A. Lindsley
ASAnna Sheridan
Anna Sheridan
DBDevang L. Bhoiwala
Devang L. Bhoiwala
SHShazaan F. Hushmendy
Shazaan F. Hushmendy
DCDana Crawford
Dana Crawford
We previously showed a preferential degradation and down-regulation of mitochondrial DNA and RNA in hamster fibroblasts in response to hydrogen peroxide. Subsequent studies by others demonstrated that mitochondrial DNA can stimulate immune cells as a

1 February 2010 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ZIZoran Ilic
Zoran Ilic
DCDana Crawford
Dana Crawford
PEPatricia A. Egner
Patricia A. Egner
SSStewart Sell
Stewart Sell

1 August 2009 in Nutrition Research
Verified
Journal Article
Closed access
SHShazaan Hushmendy
Shazaan Hushmendy
LJLalithapriya Jayakumar
Lalithapriya Jayakumar
AHAmy B. Hahn
Amy B. Hahn
DBDevang Bhoiwala
Devang Bhoiwala
DBDipti L. Bhoiwala
Dipti L. Bhoiwala
DCDana Crawford
Dana Crawford

23 May 2017 in Carcinogenesis
Verified
Journal Article
Open access
PDF file
DCDana Crawford
Dana Crawford
ZIZoran Ilic
Zoran Ilic
IGIan Guest
Ian Guest
GMGinger L. Milne
Ginger L. Milne
JHJohn Hayes
John Hayes
SSStewart Sell
Stewart Sell
We recently generated glutathione S-transferase (GST) A3 knockout (KO) mice as a novel model to study the risk factors for liver cancer. GSTA3 KO mice are sensitive to the acute cytotoxic and genotoxic effects of aflatoxin B1 (AFB1), confirming the crucial role of GSTA3 in resistance to AFB1. We now report histopathological changes, tumor formation, biochemical changes and gender response following AFB1 treatment as well as the contribution of oxidative stress. Using a protocol of weekly 0.5 mg AFB1/kg administration, we observed extensive oval (liver stem) cell (OC) proliferation within 1–3 weeks followed by microvesicular lipidosis, megahepatocytes, nuclear inclusions, cholangiomas and small nodules. Male and female GSTA3 KO mice treated with 12 and 24 weekly AFB1 injections followed by a rest period of 12 and 6 months, respectively, all had grossly distorted livers with macro- and microscopic cysts, hepatocellular nodules, cholangiomas and cholangiocarcinomas and OC proliferation. We postulate that the prolonged AFB1 treatment leads to inhibition of hepatocyte proliferation, which is compensated by OC proliferation and eventually formation of cholangiocarcinoma (CCA). At low-dose AFB1, male KO mice showed less extensive acute liver injury, OC proliferation and AFB1-DNA adducts than female KO mice. There were no significant compensatory changes in KO mice GST subunits, GST enzymatic activity, epoxide hydrolase, or CYP1A2 and CYP3A11 levels. Finally, there was a modest increase in F2-isoprostane and isofuran in KO mice that confirmed putative GSTA3 hydroperoxidase activity in vivo for the first time.

15 August 2004 in Free Radical Biology and Medicine
Verified
Journal Article
Closed access
HMHenry J Michtalik
Henry J Michtalik
ANAnanth V Narayan
Ananth V Narayan
NBNishant Bhatt
Nishant Bhatt
HLH.Y Lin
H.Y Lin
MMMichael T Mulligan
Michael T Mulligan
DCDana Crawford
Dana Crawford